Healthcare -
Biotechnology - NASDAQ - US
$ 3.34
2.77 %
$ 213 M
Market Cap
-2.9
P/E
LRMR - SHORT-TERM DEBT
Short-term Debt LRMR - Larimar Therapeutics, Inc.
837 K
LAST VALUE
-16.06%
2 YEAR CAGR
-31.26%
5 YEAR CAGR
0.00%
10 YEAR CAGR